| Literature DB >> 27169667 |
Tayita Suttirojpattana1,2, Tamas Somfai2, Satoko Matoba2, Rangsun Parnpai1, Takashi Nagai3, Masaya Geshi2.
Abstract
Our aim was to improve the developmental competence of bovine oocytes during their liquid storage by using additives. In vitro matured oocytes were stored for 20 h at 25°C in HEPES buffered TCM 199 medium (base medium). After storage, in vitro embryo development after in vitro fertilization was compared to those of non-stored (control) ones. Addition of 10% (v/v) newborn calf serum or 10.27 mmol/L pyruvate alone to the base medium did not improve blastocyst formation rates in stored oocytes; however, their simultaneous addition significantly improved the rate compared with those stored in base medium (P < 0.05). Supplementation of the holding medium with dithiothreitol (DTT) at any concentrations did not improve embryo development from stored oocytes. Although supplementation with cyclosporine A (CsA) significantly reduced apoptosis and membrane damage rates during storage, it did not improve the developmental competence of oocytes. 1,2-bis(2-aminophenoxy) ethane N,N,N',N'-tetraacetic acid tetrakis-acetoxymethyl ester and ruthenium red had no effect on oocyte apoptotic rates. Blastocyst formation rates in all stored groups remained significantly lower than that of the control. In conclusion, pyruvate and serum had a synergic effect to moderate the reduction of oocyte quality during storage, whereas mitochondrial membrane pore inhibitor CsA and the antioxidant DTT did not affect their developmental competence.Entities:
Keywords: additives; bovine; in vitro fertilization; oocyte; storage
Mesh:
Substances:
Year: 2016 PMID: 27169667 PMCID: PMC5298027 DOI: 10.1111/asj.12623
Source DB: PubMed Journal: Anim Sci J ISSN: 1344-3941 Impact factor: 1.749
Effect of additives in storage medium on development of stored† oocytes after in vitro fertilization (IVF)
|
| Total no. of oocytes used for IVF | No. of oocytes cleaved, % (mean ± SEM) | No. of oocytes developed to the blastocyst stage on | ||
|---|---|---|---|---|---|
| day 7, % (mean ± SEM) | day 8, % (mean ± SEM) | day 9, % (mean ± SEM) | |||
|
| 210 | 155 (73.1 ± 4.6) | 87 (40.8 ± 3.9a) | 94 (44.0 ± 4.1a) | 94 (44.0 ± 4.1a) |
|
| 214 | 149 (68.9 ± 5.3) | 14 (6.1 ± 2.2b) | 16 (7.2 ± 2.3b) | 16 (7.2 ± 2.3b) |
|
| 208 | 159 (76.6 ± 4.7) | 21 (10.3 ± 1.7bc) | 23 (11.4 ± 2.0b) | 23 (11.4 ± 2.0b) |
|
| 211 | 152 (71.4 ± 3.9) | 28 (13.2 ± 1.2bc) | 29 (13.8 ± 1.8bc) | 30 (14.3 ± 1.7bc) |
|
| 219 | 180 (81.8 ± 4.0) | 38 (17.1 ± 2.0c) | 46 (21.0 ± 3.1c) | 46 (21.0 ± 3.1c) |
Oocytes were stored for 20 h. Five replicates were performed. Values in the same column with no common superscripts differ significantly (P < 0.05). Day 0 = the day of IVF. NCS = 10% (v/v) newborn calf serum. Pyru = 10.27 mmol/L pyruvate.
Effect of additives in storage medium for bovine oocytes on ability of blastocysts obtained from in vitro fertilization (IVF) of stored† oocytes to hatch during in vitro embryo culture (IVC)
|
| No. of blastocysts examined | No. of blastocysts hatching/hatched on day 8, % (mean ± SEM) | No. of blastocystshatching/hatched on day 9, % (mean ± SEM) |
|---|---|---|---|
|
| 94 | 57 (60.4 ± 5.8) | 68 (73.4 ± 3.9a) |
|
| 16 | 7 (28.0 ± 12.7) | 8 (31.3 ± 15.4b) |
|
| 23 | 11 (46.7 ± 11.0) | 13 (56.7 ± 13.3ab) |
|
| 30 | 12 (37.8 ± 16.5) | 16 (54.0 ± 15.2ab) |
|
| 46 | 16 (33.2 ± 7.6) | 22 (46.2 ± 9.8ab) |
Oocytes were stored for 20 h. Five replicates were performed. Values in the same column with no common superscripts differ significantly (P < 0.05).
Day 0 = the day of IVF. NCS = 10% (v/v) newborn calf serum. Pyru = 10.27 mmol/L pyruvate. IVM, IV maturation.
Effect of dithiothreitol (DTT) supplementation in storage medium for bovine oocytes on their subsequent development after in vitro fertilization (IVF)
|
| DTT concentration (mmol/L) during storage | No. of oocytes used for IVF | No. of oocytes cleaved, % (mean ± SEM) | No. of oocytes developed to the blastocyst stage on | ||
|---|---|---|---|---|---|---|
| day 7, % (mean ± SEM) | day 8, % (mean ± SEM) | day 9, % (mean ± SEM) | ||||
| – | NA | 149 | 105 (71.5 ± 5.2a) | 55 (37.5 ± 5.9a) | 55 (37.5 ± 5.9a) | 55 (37.5 ± 5.9a) |
|
| 0 | 146 | 112 (74.9 ±6.0a) | 24 (16.2 ± 1.5bc) | 26 (17.7 ± 2.2bc) | 27 (18.2 ± 2.4c) |
|
| 0.05 | 142 | 111 (78.8 ± 1.7a) | 28 (20.2 ± 1.9c) | 30 (21.3 ± 0.8c) | 30 (21.3 ± 0.8c) |
|
| 0.5 | 137 | 85 (63.8 ± 6.4a) | 18 (13.3 ± 0.5bc) | 19 (14.2 ± 1.3bc) | 19 (14.2 ± 1.3bc) |
|
| 1 | 131 | 86 (66.0 ± 1.6a) | 23 (18.0 ± 2.2c) | 23 (18.0 ± 2.2c) | 23 (18.0 ± 2.2c) |
|
| 5 | 104 | 39 (36.5 ± 8.8b) | 9 (8.8 ± 1.8b) | 9 (8.8 ± 1.8b) | 9 (8.8 ± 1.8b) |
Oocytes were stored for 20 h. Three replicates were performed. Values in the same column with no common superscripts differ significantly (P < 0.05).
Day 0 = the day of IVF. The holding medium for oocyte storage was base medium supplemented with 10.27 mmol/L pyruvate. IVM, IV maturation.
Effect of dithiothreitol (DTT) supplementation in storage medium for bovine oocytes on ability of blastocysts obtained from in vitro fertilization (IVF) of stored† oocytes to hatch after in vitro embryo culture (IVC)
|
| DTT concentration (mmol/L) during storage | No. of blastocysts examined | No. of blastocysts hatching/hatched on day 8, % (mean ± SEM) | No. of blastocysts hatching/hatched on day 9, % (mean ± SEM) |
|---|---|---|---|---|
| – | NA | 55 | 40 (70.5 ± 6.6a) | 47 (84.7 ± 4.0a) |
|
| 0 | 27 | 16 (58.8 ± 5.6ab) | 18 (65.1 ± 4.2ab) |
|
| 0.05 | 30 | 18 (59.7 ± 2.0ab) | 19 (62.5 ± 2.8ab) |
|
| 0.5 | 19 | 11 (57.1 ± 12.0ab) | 13 (68.2 ± 9.8ab) |
|
| 1 | 23 | 8 (35.1 ± 11.5b) | 12 (52.4 ± 7.6b) |
|
| 5 | 9 | 3 (30.6 ± 19.4b) | 5 (47.2 ± 23.7b) |
Oocytes were stored for 20 h. Three replicates were performed. Values in the same column with no common superscripts differ significantly (P < 0.05). Day 0 = the day of IVF. The holding medium for oocyte storage was base medium supplemented with 10.27 mmol/L pyruvate. IVM, IV maturation.
Effects of cytosolic Ca2+ modulating agents during storage† of bovine oocytes on their live/dead status and apoptosis
|
| Additive during storage | No. of oocytes examined | No. of oocytes categorized as A‐/PI‐, % (mean ± SEM) | No. of oocytes categorized as A+/PI‐, % (mean ± SEM) | No. of oocytes categorized as PI+, % (mean ± SEM) |
|---|---|---|---|---|---|
| – |
| 140 | 131 (94.0 ± 3.5a) | 6 (4.0 ± 3.0a) | 3 (2.0 ± 1.2a) |
|
|
| 144 | 108 (74.6 ± 6.0bc) | 13 (9.2 ± 3.6a) | 23 (16.1 ± 2.8c) |
|
|
| 146 | 118 (80.9 ± 2.0bc) | 18 (12.3 ± 1.9a) | 10 (6.8 ± 0.3ab) |
|
|
| 141 | 87 (61.7 ± 3.2b) | 37 (26.2 ± 3.6b) | 17 (12.0 ± 0.6bc) |
|
|
| 143 | 129 (90.0 ± 5.9ac) | 9 (6.5 ± 3.4a) | 6 (4.3 ± 2.2a) |
Oocytes were stored for 20 h. Three replicates were performed. Values in the same column with no common superscripts differ significantly (P < 0.05). The holding medium for oocyte storage was base medium supplemented with 10.27 mmol/L pyruvate.
IVM, IV maturation
BAPTA = 1,2‐bis(2‐aminophenoxy) ethane N,N,N’,N’‐tetraacetic acid tetrakis‐acetoxymethyl ester
RR = ruthenium red
CsA = cyclosporin A
A‐/PI‐ = viable non‐apoptotic oocyte; A+/PI‐ = early apoptotic oocyte; PI+ = dead oocyte
Effect of cyclosporin A (CsA) supplementation in storage medium for bovine oocytes on subsequent development after in vitro fertilization (IVF)
|
| CsA concentration (µmol/L) during storage | No. of oocytes used for IVF | No. of oocytes cleaved, % (mean ± SEM) | No. of oocytes developed to the blastocyst stage on | ||
|---|---|---|---|---|---|---|
| day 7, % (mean ± SEM) | day 8, % (mean ± SEM) | day 9, % (mean ± SEM) | ||||
| – | NA | 284 | 196 68.5 ± 2.6a | 102 (35.6 ± 2.2a) | 108 (37.6 ± 1.9a) | 113 (39.3 ± 1.7a) |
|
| 0 | 273 | 197 72.9 ± 4.0a | 46 (18.1 ± 3.8b) | 50 (19.8 ± 4.2b) | 50 (19.8 ± 4.2b) |
|
| 1 | 267 | 189 71.1 ± 2.0a | 29 (10.9 ± 2.0b) | 32 (11.9 ± 1.6b) | 34 (12.6 ± 1.2b) |
|
| 33 | 278 | 230 83.9 ± 3.1b | 52 (18.7 ± 2.5b) | 55 (19.9 ± 2.1b) | 55 (19.9 ± 2.1b) |
Oocytes were stored for 20 h. Five Replicates were performed. Values in the same column with no common superscripts differ significantly (P < 0.05). Day 0 = the day of IVF. The holding medium for oocyte storage was base medium supplemented with 10.27 mmol/L pyruvate. IVM, IV maturation.
Effect of cyclosporin A (CsA) supplementation during oocyte storage for 20 h on the hatching ability of resultant blastocysts
|
| CsA concentration (µmol/L) during storage | Total | Hatching day 8, % (mean ± SEM) | Hatching day 9, % (mean ± SEM) |
|---|---|---|---|---|
|
| NA | 113 | 80 (75.6 ± 3.9) | 90 (79.8 ± 4.2) |
|
| 0 | 50 | 30 (61.4 ± 8.6) | 31 (62.9 ± 7.6) |
|
| 1 | 34 | 21 (70.9 ± 9.6) | 24 (72.5 ± 9.0) |
|
| 33 | 55 | 33 (60.2 ± 4.6) | 34 (61.3 ± 4.7) |
Five replicates were performed. Values in the same column with no common superscripts differ significantly (P < 0.05). Day 0 = the day of IVF. The holding medium for oocyte storage was base medium supplemented with 10.27 mmol/L pyruvate.
Effect of cyclosporin A (CsA) supplementation during oocyte storage for 20 h on total cell number of resultant blastocysts derived from in vitro fertilization (IVF)
|
| CsA concentration (µmol/L) during storage | Total | Total cell number, mean ± SEM |
|---|---|---|---|
|
| NA | 110 | 254.7 ± 20.4 |
|
| 0 | 45 | 228.3 ± 27.6 |
|
| 1 | 33 | 214.8 ± 21.9 |
|
| 33 | 55 | 223.7 ± 12.5 |
Five replicates were performed. Values in the same column with no common superscripts differ significantly (P < 0.05). The holding medium for oocyte storage was base medium supplemented with 10.27 mmol/L pyruvate.